Health Care & Life Sciences » Pharmaceuticals | Ocular Therapeutix Inc.

Ocular Therapeutix Inc.

Ocular Therapeutix Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
38.59 M
Public Float
31.96 M
Ocular Therapeutix Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.63
Market Cap
$220.61 M
Shares Outstanding
42.84 M
Public Float
34.79 M

Profile

Address
15 Crosby Drive
Bedford Massachusetts 01730
United States
Employees -
Website http://www.ocutx.com
Updated 07/08/2019
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S.

Financials

View All

Amarpreet S. Sawhney
Executive Chairman
Antony Mattessich
President, Chief Executive Officer & Director